造血-话题@MedSci

#造血#

356篇内容 | 2735人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1494534, encodeId=83d4149453410, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=造血干细胞移植人人都有供者, objectType=article, longId=89711, objectId=dfc189e117e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfc189e117e, replyNumber=0, likeNumber=61, createdTime=2017-02-24, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfc189e117e, moduleTitle=造血干细胞移植人人都有供者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfc189e117e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494533, encodeId=8cd9149453373, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Neurology：复发缓解型多发性硬化患者接受高剂量的免疫抑制治疗和自体造血干细胞移植疗效如何？, objectType=article, longId=88667, objectId=68e38866e90, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68e38866e90, replyNumber=0, likeNumber=65, createdTime=2017-02-14, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68e38866e90, moduleTitle=Neurology：复发缓解型多发性硬化患者接受高剂量的免疫抑制治疗和自体造血干细胞移植疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68e38866e90)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494532, encodeId=f60f149453287, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Science子刊：利用CRISPR/Cas9修复源自罕见免疫缺陷病患者的造血干细胞基因缺陷, objectType=article, longId=87555, objectId=f1e38e55501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1e38e55501, replyNumber=0, likeNumber=44, createdTime=2017-01-17, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1e38e55501, moduleTitle=Science子刊：利用CRISPR/Cas9修复源自罕见免疫缺陷病患者的造血干细胞基因缺陷, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1e38e55501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494531, encodeId=bd63149453173, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=人造血液何时替代人血？, objectType=article, longId=87341, objectId=9ad68e341af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ad68e341af, replyNumber=0, likeNumber=65, createdTime=2017-01-13, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ad68e341af, moduleTitle=人造血液何时替代人血？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ad68e341af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494530, encodeId=fa9714945305b, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=西南大学90后研究生无偿捐献造血干细胞, objectType=article, longId=87008, objectId=81e08e008c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81e08e008c3, replyNumber=0, likeNumber=61, createdTime=2017-01-10, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81e08e008c3, moduleTitle=西南大学90后研究生无偿捐献造血干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81e08e008c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494529, encodeId=f15e1494529cd, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=J Exp Med：动物所揭示5-羟色胺调控造血干细胞发育机制, objectType=article, longId=86474, objectId=bef9864e4e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bef9864e4e4, replyNumber=0, likeNumber=66, createdTime=2017-01-05, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bef9864e4e4, moduleTitle=J Exp Med：动物所揭示5-羟色胺调控造血干细胞发育机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bef9864e4e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494528, encodeId=00f2149452895, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JEM：中科院刘峰教授揭示5-羟色胺调控造血干细胞发育的机制, objectType=article, longId=86379, objectId=f129863e9cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f129863e9cf, replyNumber=0, likeNumber=90, createdTime=2017-01-03, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f129863e9cf, moduleTitle=JEM：中科院刘峰教授揭示5-羟色胺调控造血干细胞发育的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f129863e9cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494527, encodeId=fe78149452e76, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JAAD：造血干细胞移植后白癜风的危险因素有哪些？, objectType=article, longId=82265, objectId=29538226501, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29538226501, replyNumber=0, likeNumber=48, createdTime=2016-11-14, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29538226501, moduleTitle=JAAD：造血干细胞移植后白癜风的危险因素有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29538226501)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494526, encodeId=5fa814945264c, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=【盘点】有关造血干细胞移植相关研究汇总, objectType=article, longId=81085, objectId=f4a581085cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4a581085cc, replyNumber=0, likeNumber=67, createdTime=2016-10-28, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4a581085cc, moduleTitle=【盘点】有关造血干细胞移植相关研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4a581085cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494524, encodeId=04ec149452401, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=JCI：造血干细胞甲基化可预测AML患者的化疗疗效, objectType=article, longId=80844, objectId=f4678084463, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4678084463, replyNumber=0, likeNumber=71, createdTime=2016-10-26, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4678084463, moduleTitle=JCI：造血干细胞甲基化可预测AML患者的化疗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4678084463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494525, encodeId=4c67149452543, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Science：缬氨酸缺乏会耗竭造血干细胞, objectType=article, longId=80847, objectId=1db28084ef8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1db28084ef8, replyNumber=0, likeNumber=65, createdTime=2016-10-26, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1db28084ef8, moduleTitle=Science：缬氨酸缺乏会耗竭造血干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1db28084ef8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494523, encodeId=0b021494523a4, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=单倍型造血干细胞移植为患者带来希望, objectType=article, longId=80655, objectId=011280655d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=011280655d7, replyNumber=0, likeNumber=65, createdTime=2016-10-23, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=011280655d7, moduleTitle=单倍型造血干细胞移植为患者带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=011280655d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494522, encodeId=f5f81494522ba, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nat Commun:人造血管获突破，可在受体内自行生长, objectType=article, longId=79080, objectId=60f8e908078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f8e908078, replyNumber=0, likeNumber=60, createdTime=2016-10-02, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f8e908078, moduleTitle=Nat Commun:人造血管获突破，可在受体内自行生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f8e908078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494521, encodeId=03171494521b8, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Nat Com：实验室开发人造血管移植后可在大型动物体内生长, objectType=article, longId=78966, objectId=4ff6e896670, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff6e896670, replyNumber=0, likeNumber=53, createdTime=2016-10-01, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff6e896670, moduleTitle=Nat Com：实验室开发人造血管移植后可在大型动物体内生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ff6e896670)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494520, encodeId=44fd1494520b3, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=2016ECIL-5建议——血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理发布, objectType=article, longId=77140, objectId=3326e714088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3326e714088, replyNumber=0, likeNumber=22, createdTime=2016-09-11, rootId=0, userName=俅侠, userId=caed9138962, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3326e714088, moduleTitle=2016ECIL-5建议——血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3326e714088)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494519, encodeId=0d54149451985, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=2016造血与淋巴组织肿瘤检验诊断报告模式专家共识发布, objectType=article, longId=76576, objectId=5db7e6576d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5db7e6576d0, replyNumber=0, likeNumber=26, createdTime=2016-09-04, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5db7e6576d0, moduleTitle=2016造血与淋巴组织肿瘤检验诊断报告模式专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5db7e6576d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494518, encodeId=77ad149451808, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Cell：重大发现！首次揭示蛋白ANG双管齐下促进造血系统重建, objectType=article, longId=75139, objectId=dd5de51390c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd5de51390c, replyNumber=0, likeNumber=55, createdTime=2016-08-16, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd5de51390c, moduleTitle=Cell：重大发现！首次揭示蛋白ANG双管齐下促进造血系统重建, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd5de51390c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494517, encodeId=cd04149451e7d, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=临床试验！科学家利用异体造血干细胞来治疗阿尔兹海默氏症, objectType=article, longId=74620, objectId=991ee4620a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=991ee4620a8, replyNumber=0, likeNumber=64, createdTime=2016-08-08, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=991ee4620a8, moduleTitle=临床试验！科学家利用异体造血干细胞来治疗阿尔兹海默氏症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=991ee4620a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494516, encodeId=0ddd1494516e3, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=用基因编辑、人造血、大脑芯片打造超级人类？美国人不太接受, objectType=article, longId=74001, objectId=94f5e400123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94f5e400123, replyNumber=0, likeNumber=66, createdTime=2016-07-30, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94f5e400123, moduleTitle=用基因编辑、人造血、大脑芯片打造超级人类？美国人不太接受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94f5e400123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1494515, encodeId=9a2a149451592, content=<a href='/topic/show?id=084d9499599' target=_blank style='color:#2F92EE;'>#造血#</a>, objectTitle=Cell Stem Cell：新研究揭示中枢神经系统如何调节胚胎期造血干细胞和祖细胞形成, objectType=article, longId=73385, objectId=4cd8e33852e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cd8e33852e, replyNumber=0, likeNumber=69, createdTime=2016-07-23, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cd8e33852e, moduleTitle=Cell Stem Cell：新研究揭示中枢神经系统如何调节胚胎期造血干细胞和祖细胞形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cd8e33852e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血

2020-05-29

俅侠 (审核中...)

前往app查看评论内容

#造血#

造血干细胞移植人人都有供者

2017-02-24

俅侠 (审核中...)

前往app查看评论内容

#造血#

Neurology：复发缓解型多发性硬化患者接受高剂量的免疫抑制治疗和自体造血干细胞移植疗效如何？

2017-02-14

俅侠 (审核中...)

前往app查看评论内容

#造血#

Science子刊：利用CRISPR/Cas9修复源自罕见免疫缺陷病患者的造血干细胞基因缺陷

2017-01-17

俅侠 (审核中...)

前往app查看评论内容

#造血#

人造血液何时替代人血？

2017-01-13

俅侠 (审核中...)

前往app查看评论内容

#造血#

西南大学90后研究生无偿捐献造血干细胞

2017-01-10

俅侠 (审核中...)

前往app查看评论内容

#造血#

J Exp Med：动物所揭示5-羟色胺调控造血干细胞发育机制

2017-01-05

俅侠 (审核中...)

前往app查看评论内容

#造血#

JEM：中科院刘峰教授揭示5-羟色胺调控造血干细胞发育的机制

2017-01-03

俅侠 (审核中...)

前往app查看评论内容

#造血#

JAAD：造血干细胞移植后白癜风的危险因素有哪些？

2016-11-14

俅侠 (审核中...)

前往app查看评论内容

#造血#

【盘点】有关造血干细胞移植相关研究汇总

2016-10-28

俅侠 (审核中...)

前往app查看评论内容

#造血#

JCI：造血干细胞甲基化可预测AML患者的化疗疗效

2016-10-26

俅侠 (审核中...)

前往app查看评论内容

#造血#

Science：缬氨酸缺乏会耗竭造血干细胞

2016-10-26

俅侠 (审核中...)

前往app查看评论内容

#造血#

单倍型造血干细胞移植为患者带来希望

2016-10-23

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nat Commun:人造血管获突破，可在受体内自行生长

2016-10-02

俅侠 (审核中...)

前往app查看评论内容

#造血#

Nat Com：实验室开发人造血管移植后可在大型动物体内生长

2016-10-01

俅侠 (审核中...)

前往app查看评论内容

#造血#

2016ECIL-5建议——血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理发布

2016-09-11

医者仁心 (审核中...)

前往app查看评论内容

#造血#

2016造血与淋巴组织肿瘤检验诊断报告模式专家共识发布

2016-09-04

医者仁心 (审核中...)

前往app查看评论内容

#造血#

Cell：重大发现！首次揭示蛋白ANG双管齐下促进造血系统重建

2016-08-16

医者仁心 (审核中...)

前往app查看评论内容

#造血#

临床试验！科学家利用异体造血干细胞来治疗阿尔兹海默氏症

2016-08-08

医者仁心 (审核中...)

前往app查看评论内容

#造血#

用基因编辑、人造血、大脑芯片打造超级人类？美国人不太接受

2016-07-30

医者仁心 (审核中...)

前往app查看评论内容

#造血#

Cell Stem Cell：新研究揭示中枢神经系统如何调节胚胎期造血干细胞和祖细胞形成

2016-07-23

科室
- - 订阅+
  - 更多科室
工具
服务